Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate
about
sameAs
ACRATA: a novel electron transfer domain associated to apoptosis and cancerRecognition of six-transmembrane epithelial antigen of the prostate-expressing tumor cells by peptide antigen-induced cytotoxic T lymphocytesThe Steap proteins are metalloreductasesIdentification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cellsProstate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms.Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsDendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in miceAdoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.Identification of novel vascular targets in lung cancer.PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesImmunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.Prostate stem cell antigen: a prospective therapeutic and diagnostic target.DNA Vaccines for Prostate Cancer.DNA vaccination for prostate cancer: key concepts and considerations.Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines.Development of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways.
P2860
Q24557443-627BEEC1-43C8-46FF-9ACD-F499E75A55AAQ24672952-CCEBF0A1-16AE-4198-B781-70C22CC6100AQ24681553-93F714D7-A5A9-42BC-AA70-4B935313BD45Q28594532-3F02C585-57D2-4FE0-93C7-C5EA5965D5C0Q33606027-0BD0B259-8620-4936-A8C0-8D7BEF49AD63Q33694988-302908A8-5991-4D03-B083-515EF7323673Q33880106-0C038CE8-586F-48E1-8666-5F9918EACA78Q33936327-9973BF08-DA0F-412D-91E9-DE2D0C40BEFCQ34472125-637BA287-0B56-426A-BDA0-35E74C96937AQ34590434-6F5BF88D-A4F5-45AC-AE70-0800D9B5EBA2Q35677838-B2B1E833-DF25-4FD3-AC45-AB00E70C44ACQ35972569-C5F78296-97C5-4937-87B8-3AF58A563352Q36491182-33E0AEBF-CAF7-4250-B72C-14C43C00F941Q36887869-5DB90430-93D7-4D58-9211-40EECCD2C90AQ36936564-B94A1F20-B9F5-4038-AEA7-E07C7B66B1D2Q37186552-FFE9BB62-483B-4A82-96A0-1C4EBA7F9323Q37604481-F9C87EDD-46E5-406E-BC19-462CA85ADB1CQ38544772-7937D581-EB58-40CA-9FDA-F4E06D98919AQ39064900-715F7198-BD26-484C-82EE-24B3C5BD763BQ39507581-B0C13CDB-EF02-4EAA-B05A-8570823E34BAQ42536013-BC6EC50F-8FE7-4D85-89FE-CF03A574792AQ47154025-8B8B83E9-5C42-42E1-8F0B-E3CCA7D90C34Q47549076-B4AA3C47-465C-401C-B364-32FE7E270944
P2860
Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@en
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@nl
type
label
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@en
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@nl
prefLabel
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@en
Murine six-transmembrane epith ...... adenocarcinoma mouse prostate
@nl
P2093
P3181
P1433
P1476
Murine six-transmembrane epith ...... ocarcinoma mouse prostate mice
@en
P2093
P304
P3181
P407
P577
2001-08-01T00:00:00Z